Search for other papers by Anne H van der Spek in
Google Scholar
PubMed
Search for other papers by Olga V Surovtseva in
Google Scholar
PubMed
Search for other papers by Saskia Aan in
Google Scholar
PubMed
Search for other papers by Anton T J Tool in
Google Scholar
PubMed
Search for other papers by Annemarie van de Geer in
Google Scholar
PubMed
Search for other papers by Korcan Demir in
Google Scholar
PubMed
Search for other papers by Anja L M van Gucht in
Google Scholar
PubMed
Search for other papers by A S Paul van Trotsenburg in
Google Scholar
PubMed
Search for other papers by Timo K van den Berg in
Google Scholar
PubMed
Search for other papers by Eric Fliers in
Google Scholar
PubMed
Search for other papers by Anita Boelen in
Google Scholar
PubMed
immune response. To answer this, we assessed circulating pro-inflammatory cytokine levels in a previously described patient with RTHα ( 19 ) and found elevated concentrations of interleukin-8 (IL-8). We then measured IL-8 in a larger cohort of 8 RTHα
Search for other papers by Clara Lundetoft Clausen in
Google Scholar
PubMed
Search for other papers by Trine Holm Johannsen in
Google Scholar
PubMed
Search for other papers by Niels Erik Skakkebæk in
Google Scholar
PubMed
Search for other papers by Hanne Frederiksen in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Anders Juul in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Thomas Benfield in
Google Scholar
PubMed
important inhibitory effects towards pro-inflammatory mediators such as interleukin 6 (IL-6) ( 10 ). Therefore, in appropriate responses to critical illness and hyperinflammation, glucocorticoid levels are upregulated, attaining levels up to six
Search for other papers by R A M Quax in
Google Scholar
PubMed
Search for other papers by J A M van Laar in
Google Scholar
PubMed
Search for other papers by R van Heerebeek in
Google Scholar
PubMed
Search for other papers by K Greiner in
Google Scholar
PubMed
Search for other papers by E Ben-Chetrit in
Google Scholar
PubMed
Search for other papers by M Stanford in
Google Scholar
PubMed
Search for other papers by G R Wallace in
Google Scholar
PubMed
Search for other papers by F Fortune in
Google Scholar
PubMed
Search for other papers by M Ghabra in
Google Scholar
PubMed
Search for other papers by M Soylu in
Google Scholar
PubMed
Search for other papers by J M W Hazes in
Google Scholar
PubMed
Search for other papers by S W J Lamberts in
Google Scholar
PubMed
Search for other papers by J H Kappen in
Google Scholar
PubMed
Search for other papers by P M van Hagen in
Google Scholar
PubMed
Search for other papers by J W Koper in
Google Scholar
PubMed
Search for other papers by R A Feelders in
Google Scholar
PubMed
.001), whereas the mean K D (95% CI) of the receptor did not differ between patients (8.34, 6.62–10.50 nM) and controls (8.46, 7.37–9.71 nM). Importantly, the EC 50 values of GILZ and IL2 and the number of GR did not differ significantly between Caucasian and
Search for other papers by Marianna Martino in
Google Scholar
PubMed
Search for other papers by Paolo Falcioni in
Google Scholar
PubMed
Search for other papers by Giulia Giancola in
Google Scholar
PubMed
Search for other papers by Alessandro Ciarloni in
Google Scholar
PubMed
Search for other papers by Gianmaria Salvio in
Google Scholar
PubMed
Search for other papers by Francesca Silvetti in
Google Scholar
PubMed
Search for other papers by Augusto Taccaliti in
Google Scholar
PubMed
Search for other papers by Giorgio Arnaldi in
Google Scholar
PubMed
with more severe pneumonia, but did not find any significant differences in IL-6 levels between severe and non-severe COVID-19 pneumonia ( 34 ). If the relationship between hyponatremia and COVID-19 pneumonia is a matter of fact ( 24 , 28 , 29 , 30
Search for other papers by Shin-ya Ueda in
Google Scholar
PubMed
Search for other papers by Hidehiro Nakahara in
Google Scholar
PubMed
Search for other papers by Eriko Kawai in
Google Scholar
PubMed
Search for other papers by Tatsuya Usui in
Google Scholar
PubMed
Search for other papers by Shintaro Tsuji in
Google Scholar
PubMed
Search for other papers by Tadayoshi Miyamoto in
Google Scholar
PubMed
.7 ± 1.6 * Walking speed (km/h) 6.6 ± 0.9 6.0 ± 0.5 ** Biochemical parameters Glucose (mg/dL) 91.6 ± 8.1 90.4 ± 8.9 NS Insulin (μU/mL) 3.7 ± 2.8 3.6 ± 2.4 NS IL-6 (pg/mL) 0.45 ± 0.4 1.34 ± 0
Search for other papers by A Chinoy in
Google Scholar
PubMed
Search for other papers by M Skae in
Google Scholar
PubMed
Search for other papers by A Babiker in
Google Scholar
PubMed
Search for other papers by D Kendall in
Google Scholar
PubMed
Search for other papers by M Z Mughal in
Google Scholar
PubMed
Search for other papers by R Padidela in
Google Scholar
PubMed
/mmol ( 2 )) demonstrated with cCa >1.9 mmol/L. Given these challenges, subcutaneous injections of teriparatide – recombinant human PTH(1–34) (rhPTH(1–34) was initiated on an off-licence basis (dose 0.4 μg/kg twice-daily)). This established acceptable cCa
Search for other papers by Huiyuan Zhai in
Google Scholar
PubMed
Search for other papers by Dongxu Wang in
Google Scholar
PubMed
Search for other papers by Yong Wang in
Google Scholar
PubMed
Search for other papers by Hongwei Gu in
Google Scholar
PubMed
Search for other papers by Juan Jv in
Google Scholar
PubMed
Search for other papers by Liangliang Yuan in
Google Scholar
PubMed
Search for other papers by Chao Wang in
Google Scholar
PubMed
Search for other papers by Leiyao Chen in
Google Scholar
PubMed
display heightened levels of circulating inflammatory markers such as tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6), IL-1β, and monocyte chemoattractant protein 1 (MCP-1), as well as decreased plasma levels of anti-inflammatory cytokines
School of Medicine, Universidad de los Andes, Bogotá, Colombia
Search for other papers by Jairo Arturo Pinzón-Cortés in
Google Scholar
PubMed
Search for other papers by Angelina Perna-Chaux in
Google Scholar
PubMed
Search for other papers by Nicolás Steven Rojas-Villamizar in
Google Scholar
PubMed
Search for other papers by Angélica Díaz-Basabe in
Google Scholar
PubMed
Search for other papers by Diana Carolina Polanía-Villanueva in
Google Scholar
PubMed
Search for other papers by María Fernanda Jácome in
Google Scholar
PubMed
Endocrinology Section, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia
Search for other papers by Carlos Olimpo Mendivil in
Google Scholar
PubMed
School of Medicine, Universidad de los Andes, Bogotá, Colombia
Search for other papers by Helena Groot in
Google Scholar
PubMed
School of Medicine, Universidad de los Andes, Bogotá, Colombia
Search for other papers by Valeriano López-Segura in
Google Scholar
PubMed
(no. of individuals) Average HbA1c (%) Average DNA methylation-5mC (ng and %) Average DNA hydroxymethylation-5hmC (ng and %) Well-controlled patients 19 48.51 ± 12.42 9.83 ± 8.09 3 0 6.06 ± 0.47 1.34 ± 0.98 ng 0
Search for other papers by Yao Chen in
Google Scholar
PubMed
Search for other papers by Shu-ying Fang in
Google Scholar
PubMed
) C677T polymorphism, peroxisome proliferator-activated receptor gamma ( PPAR-γ ) polymorphism and interleukin-1beta/IL-1 receptor antagonist ( IL-1β/IL-1Ra ) gene polymorphisms. StAR polymorphisms Hyperandrogenism accounts for most of the
Search for other papers by Michaela Keuper in
Google Scholar
PubMed
with either LPS/INFγ-activated MΦ-CM or IL10/TGFβ-activated MΦ-CM ( 34 ), using a human model system composed of SGBS cells, a human subcutaneous adipocyte model and THP1 cells, a human monocytic cell line that can be differentiated into MΦ and